|
1
|
Alhusayen R, Dienes S, Lam M, Alavi A, Alikhan A, Aleshin M, Bahashwan E, Daveluy S, Goldfarb N, Garg A, Gulliver W, Jaleel T, Kimball AB, Kirchhof MG, Kirby J, Lenczowski J, Lev-Tov H, Lowes MA, Lara-Corrales I, Micheletti R, Okun M, Orenstein L, Poelman S, Piguet V, Porter M, Resnik B, Sibbald C, Shi V, Sayed C, Wong SM, Zaenglein A, Veillette H, Hsiao JL, Naik HB. North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations. J Am Acad Dermatol 2025; 92:825-852. [PMID: 39725212 DOI: 10.1016/j.jaad.2024.11.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2024] [Revised: 11/16/2024] [Accepted: 11/23/2024] [Indexed: 12/28/2024]
Abstract
BACKGROUND Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist. OBJECTIVE To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease. METHODS Recommendations were developed using the Grading of Recommendations Assessment, Development, and Evaluation system to ascertain level of evidence and selected through a modified Delphi consensus process. RESULTS One hundred eighteen expert consensus statements are provided for the management of patients with HS across these 7 special patient populations.
Collapse
Affiliation(s)
- Raed Alhusayen
- Sunnybrook Research Institute, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
| | - Serena Dienes
- Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Megan Lam
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Afsaneh Alavi
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota
| | - Ali Alikhan
- Sutter Medical Foundation, Sacramento, California
| | - Maria Aleshin
- Department of Dermatology, Stanford University School of Medicine, Stanford, California
| | - Emad Bahashwan
- Division of Dermatology, Faculty of Medicine, University of Bisha, Bisha, Saudi Arabia
| | - Steve Daveluy
- Department of Dermatology, Wayne State University School of Medicine, Detroit, Michigan
| | - Noah Goldfarb
- Department of Dermatology, University of Minnesota, Minneapolis, Minnesota
| | - Amit Garg
- Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York
| | - Wayne Gulliver
- Department of Dermatology, Memorial University of Newfoundland, St. John's, Canada
| | - Tarannum Jaleel
- Department of Dermatology, Duke University School of Medicine, Durham, North Carolina
| | - Alexa B Kimball
- Clinical Laboratory for Epidemiology and Applied Research in Skin (CLEARS), Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts
| | - Mark G Kirchhof
- Division of Dermatology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Division of Dermatology, Department of Medicine, Ottawa Hospital, Ottawa, Ontario, Canada
| | - Joslyn Kirby
- Incyte Corporation, Wilmington, Delaware; Department of Dermatology, Penn State Health, Hershey, Pennsylvania
| | | | - Hadar Lev-Tov
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida
| | - Michelle A Lowes
- Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York
| | - Irene Lara-Corrales
- Division of Dermatology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Robert Micheletti
- Departments of Dermatology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | | | - Lauren Orenstein
- Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia
| | - Susan Poelman
- Division of Dermatology, University of Calgary and Beacon Dermatology, Calgary, Alberta, Canada
| | - Vincent Piguet
- Division of Dermatology, Department of Medicine, University of Toronto and Women's College Hospital, Toronto, Ontario, Canada
| | - Martina Porter
- Department of Dermatology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
| | - Barry Resnik
- Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida; Resnik Skin Institute, Miami, Florida
| | - Cathryn Sibbald
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Vivian Shi
- Department of Dermatology, University of Washington, Seattle, Washington
| | - Christopher Sayed
- Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
| | - Se Mang Wong
- Department of Dermatology, University of British Columbia, Vancouver, British Columbia, Canada
| | - Andrea Zaenglein
- Department of Dermatology, Penn State Health, Hershey, Pennsylvania; Penn State Children's Hospital, Hershey, Pennsylvania
| | - Helene Veillette
- Division of Dermatology, Department of Medicine, CHU de Québec-Université Laval, Québec, Canada
| | - Jennifer L Hsiao
- Department of Dermatology, University of Southern California, Los Angeles, California
| | - Haley B Naik
- Department of Dermatology, University of California, San Francisco, California
| |
Collapse
|
|
2
|
Deftereou TE, Trypidi A, Alexiadi CA, Theotokis P, Manthou ME, Meditskou S, Simopoulou M, Lambropoulou M. Congenital Herpes Simplex Virus: A Histopathological View of the Placenta. Cureus 2022; 14:e29101. [PMID: 36249599 PMCID: PMC9557870 DOI: 10.7759/cureus.29101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/12/2022] [Indexed: 11/21/2022] Open
Abstract
Congenital Herpes simplex virus (HSV) infection is considered a common pregnancy pathology that is not always easy to diagnose. This study aimed to present the spectrum of placental histopathological lesions in pregnancies complicated by HSV infection. MEDLINE and Google Scholar databases were searched using the keywords "HSV" and "placental histopathology" up to June 20, 2022. Study inclusion required presenting placental histopathological anomalies in pregnant women diagnosed with HSV infection antenatally, during labor, or postnatally. Herein, we briefly present placental pathogenesis conditions, which have been correlated with congenital HSV infection, providing clinicians with a short review describing herpetic placental pathology.
Collapse
|